Skip to main content
. Author manuscript; available in PMC: 2021 Sep 29.
Published in final edited form as: Oral Oncol. 2020 Mar 14;104:104641. doi: 10.1016/j.oraloncology.2020.104641

Table 4.

Univariate and Multivariate Analysis of Prognostic Factors for LPFS and OS

LPFS OS
Characteristics Median LPFS (months) UVA P value MVA P value MVA HR Characteristics Median OS (months) UVA P value MVA P value MVA HR
KPS at time of QS KPS at time of QS
 ≤ 70 (reference) 3.8 [3.3–4.4]  <0.001  0.001 0.54 [0.38–0.77]  ≤ 70 (reference) 4.5 [3.4–5.5]  <0.001  0.001 0.52 [0.35–0.78]
 > 70 7.0 [5.9–8.1]  > 70 8.2 [5.4–11.0]

>2 years intervals Histology
 No (reference) 4.3 [3.4–5.2]  0.026  0.104 0.74 [0.51–1.07]  SCC (reference) 6.0 [5.1–6.9]  0.019  0.005 0.51 [0.32–0.82]
 Yes 5.9 [4.9–6.9]  Others 11.3 [3.2–19.5]

RT modalities Organ dysfunction at QS
 Photon (reference) 3.5 [2.8–4.2]  0.003  0.021 0.67 [0.45–0.94]  No (reference) 7.6 [5.4–9.8]  0.019  0.57 1.12 [0.76–1.67]
 Proton 6.2 [5.3–7.2]  Yes 5.8 [4.7–6.8]

QS cycles RT modalities
 1 or 2 (reference) 2.3 [1.4–3.2]  <0.001  0.002 0.56 [0.38–0.81]  Photon (reference) 5.4 [4.0–6.8]  0.001  0.031 0.65 [0.44–0.96]
 3 or 4 6.5 [5.5–7.4]  Proton 8.3 [5.3–11.3]

Palliation achieved Concurrent therapy systemic
 No (reference) 2.8 [1.3–4.3]  <0.001  <0.001 0.41 [0.28–0.62]  No (reference) 5.3 [3.8–6.9]  0.033  0.136 0.74 [0.50–1.10]
 Yes 6.2 [5.4–6.9]  Yes 7.6 [5.9–9.3]

Age NS QS cycles
Gender NS  1 or 2 (reference) 3.9 [3.1–4.6]  <0.001  0.002 0.53 [0.35–0.79]
Histology NS  3 or 4 9.6 [6.2–13.1]

Salvage before QS Surgery NS Palliation achieved
Organ dysfunction NS  No (reference) 4.3 [3.4–5.1] <0.001 0.001 0.50 [0.33–0.77]
Concurrent treatment systemic NS  Yes 8.3 [5.4–11.1]

Age NS
Gender NS
Salvage Surgery before NS
QS
>2 years intervals NS